Abstract
Regenerative medicine is a growing field that aims to develop therapies that restore, maintain or improve tissue function. Although a number of regenerative therapies are biologically effective the vast majority of them are lacking in commercial viability. In order to translate the laboratory based biological success of regenerative medicines to large scale production capable, economic and scaleable approaches to manufacturing need to be implemented. To this end the remedi consortium are applying engineering strategies to assist in establishing regenerative medicine on a commercial footing. This paper details the application of quality engineering approaches to two stages in the manufacture of regenerative therapies: tissue scaffold fabrication and cell culture. The utility of the engineering strategies implemented is demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.J. Lysaght and A.L. Hazlehurst, “Tissue engineering: the end of the begining”, Tissue Eng., vol. 10(1–2), 2001, pp 309–320.
R Archer and D.J. Williams, “Why tissue engineering needs process engineering”, Nat. Biotechnol., vol. 23(11), 2005, pp 1353–1355.
M. Mather, S. Morgan, J. Crowe, “Meeting the needs of monitoring in tissue engineering”, Regen. Med., vol. 2(2), 2007, pp145–160
K. Shakesheff, “Supports for tissue regeneration”, Mater. Today, vol. 9(12), 2006, p 63.
V. Karageorgiou and D. Kaplan, “Porosity of 3D biomaterial scaffolds and osteogenesis”, Biomater., vol. 26, 2005, pp 5474–5491.
S.M. Howdle, M.S. Watson, M.J. Whitaker, V.K. Popov, M.C. Davies, F.S. Mandel, J. Don Wang and K.M. Shakesheff, “Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials”, Chem. Commun., 2001, pp. 109–110.
R. Donato, E.a. Miljan, S.J. Hines, et a, “Differential development of neuronal physiological responsiveness in two human neural stem cell lines”, BMC Neurosci.vol. 8: 2007, pp 36–47
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mather, M.L. et al. (2009). Remedi: A Research Consortium Applying Engineering Strategies to Establish Regenerative Medicine as a New Industry. In: Vander Sloten, J., Verdonck, P., Nyssen, M., Haueisen, J. (eds) 4th European Conference of the International Federation for Medical and Biological Engineering. IFMBE Proceedings, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-89208-3_528
Download citation
DOI: https://doi.org/10.1007/978-3-540-89208-3_528
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-89207-6
Online ISBN: 978-3-540-89208-3
eBook Packages: EngineeringEngineering (R0)